We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,176.50 +9.00 (+0.17%) Dow Futures
38,297.00 +59.00 (+0.15%) Nasdaq Futures
18,214.75 +35.50 (+0.20%) Russell 2000 Futures
2,028.80 +9.00 (+0.45%) Crude Oil
85.48 -0.18 (-0.21%) Gold
2,372.40 -1.70 (-0.07%)
GE HealthCare Technologies Inc. (GEHC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 88.21 |
| Open | 87.07 |
| Bid | 86.26 x 100 |
| Ask | 86.30 x 600 |
| Day's Range | 86.06 - 87.53 |
| 52 Week Range | 62.35 - 94.50 |
| Volume | |
| Avg. Volume | 3,651,438 |
| Market Cap | 39.372B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 28.38 |
| EPS (TTM) | 3.04 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.12 (0.14%) |
| Ex-Dividend Date | Apr 18, 2024 |
| 1y Target Est | 94.63 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GEHC
Related Research
- GE HealthCare Technologies Inc.Analyst Report: GE HealthCare Technologies IncGE HealthCare Technologies., formerly part of General Electric, provides healthcare products and technologies worldwide. The company has four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. GEHC has 50,000 employees.RatingFair ValueEconomic Moat14 days agoArgus Research
Business WireGE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase
MONTREAL, April 12, 2024--Showcase to feature key technologies, solutions that demonstrate the company’s personalized approach to transforming breast cancer imaging
Simply Wall St.Should You Be Impressed By GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) ROE?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Business Wire
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
CHICAGO, April 09, 2024--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast repla
Business WireGE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images
CHICAGO, April 03, 2024--GE HealthCare (Nasdaq: GEHC) today announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will have access to real-time, step-by-step guidance to capture diagnostic-quality images and automated ejection fraction estimation to help inform clinical decisions across cardiac settings. Vscan Air SL with
Yahoo Finance VideoGE completes split into three independent companies
General Electric has finalized its restructuring, separating into three distinct publicly-traded companies. The newly independent entities, GE Aerospace (GE) and GE Vernova (GEV), now trade individually on the New York Stock Exchange. GE Vernova will concentrate its efforts on energy transition solutions, while GE Aerospace specializes in aviation manufacturing, and GE HealthCare focuses on developing medical technology. Yahoo Finance's Josh Lipton and Julie Hyman break down the details. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. Editor's note: This article was written by Angel Smith
Business WireGE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy
CHICAGO, April 01, 2024--Less than three months after signing an agreement to acquire MIM Software Inc. ("MIM Software"), GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (Nasdaq: GEHC) is proud to announce the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. The availability of these offerings – including the MIM SurePlan and
Business WireGE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
CHICAGO, March 27, 2024--GE HealthCare (Nasdaq: GEHC) today announced the launch of Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. As a global leader in ultrasound-guided solutions in urology, this AI-based software feature is designed to support clinicians in prostate imaging, biopsies and guiding treatment. This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume. The added functionality wi
Business WireGE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health
CHICAGO, March 25, 2024--GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology. The vendor-agnostic, multi-modality nCommand Lite system will be distributed exclusively by GE HealthCare and will provide remote patient scanning support, remote access for viewing/review of images*, as well as the ability to connect to remote experts who can provide real-time guidance to the licensed technologist operating the scanner. Off-site experts can u
- Business Wire
GE HealthCare Announces Cash Dividend for First Quarter of 2024
CHICAGO, March 22, 2024--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the first quarter of 2024 payable on May 15, 2024 to all shareholders of record as of April 19, 2024.
Business WireGE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024
CHICAGO, March 22, 2024--Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| GEV GE Vernova Inc. | |||
| WAB Westinghouse Air Brake Technologies Corporation | |||
| WBD Warner Bros. Discovery, Inc. | |||
| VTRS Viatris Inc. | |||
| CTRA Coterra Energy Inc. |
Similar to GEHC
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| SOLV Solventum Corporation | |||
| TDOC Teladoc Health, Inc. | |||
| VEEV Veeva Systems Inc. | |||
| SDGR Schrödinger, Inc. | |||
| CERT Certara, Inc. |
Analyst Price Targets (13)
Upgrades & Downgrades
| Maintains | Mizuho: Buy to Buy | 4/11/2024 | |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/4/2024 | |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 | |
| Maintains | Argus Research: Buy to Buy | 4/1/2024 | |
| Initiated | HSBC: to Buy | 2/15/2024 | |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/12/2024 |
Company Profile
500 West Monroe Street
Chicago, IL 60661
United States
833 735 1139
https://www.gehealthcare.com
Sector(s): Healthcare
Industry: Health Information Services
Full Time Employees: 51,000
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
